MarketInOut Stock Screener Log In | Sign Up
 

Traws Pharma Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Traws Pharma Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.26 mln
Float10.86 mln
Earnings Date11/12/2026

Piotroski F-Score

2 / 9
Weak

Relative Strength

10 / 100
Significantly lagging

ROE

-1,260
Deeply negative

ROA

-185
Deeply negative

Business Description

Traws Pharma Inc. is a clinical-stage pharmaceutical company based in Newtown, Pennsylvania, focused on developing oral pill-based treatments for viral respiratory illnesses and cancer. Its pipeline includes drugs targeting COVID-19, seasonal flu, and bird flu, as well as cancer treatments being studied in both solid tumors and blood cancers. The company works with several licensing partners and draws on research collaborations to advance its programs. Formerly known as Onconova Therapeutics, the company adopted its current name in April 2024 and has been operating since 1998.

Key Fundamentals

EPS-1.71
ROE-1,260
ROIC-685
ROA-185
EBITDA, mln-21.42
EV / EBITDA-0.22
EV / EBIT-0.22
Revenue, mln2.79
EV / Revenue1.70

Quote Details

Last 0.3425
Change -0.0242 (-6.6%)
Open 0.351
Volume 105,252
Turnover 36,049
Average Volume 208,892

Financial Ratios

Current Ratio0.93
Price / Book5.47
Price / Sales1.81

Financial Strength

Piotroski F-Score 2 / 9
Short Ratio0.48
Short % of Float5.29

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -7.26% 13 / 100   
1 Month -38.84% 8 / 100   
2 Months -43.92% 10 / 100   
6 Months -70.47% 6 / 100   
1 Year -87.22% 6 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog